Investors & Media

Transformative science, targeted medicines

We are working to advanceĀ a deep pipeline of precision therapies, designed to allow patients to live longer, better lives. Our approach combines world-leading expertise in protein kinases with sound execution and an intense focus on discovery.

Event details

Blueprint Medicines Corp at the Morgan Stanley 15th Annual Global Healthcare Conference

Sep 13, 2017 at 9:20 AM EDT